Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has hired “a key architect” of its rival’s launch ...
Merck & Co unit MSD and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 ...
Merck KGaA Chief Executive Officer Belen Garijo says the company will continue to collaborate with the US and deliver life ...
Manthan 2026, a Research & Development Leadership Symposium, concluded successfully at Novotel, Mumbai. The insightful ...
Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...
If the Welsh Life Sciences Investment Fund had kept its full stake in Verona for the long-term it could have been a huge ...
HORSHAM, PA — MRA Group, a privately held real estate development and services firm with a multibillion-dollar footprint ...
Cognizant is learnt to have secured a deal worth over $1 billion from Swiss pharma major Novartis as part of a consolidation ...
The animal kingdom is full of examples of species that can fully regenerate their vision, but unfortunately, humans are not among them. A new study highlights that mammals aren’t without some nifty ...